BioCatalystWatch
NBIXWorkspace / NBIX / OverviewCompany library

NEUROCRINE BIOSCIENCES INC

NEUROCRINE BIOSCIENCES INC (NBIX)

Price
Market cap
Next catalystExpected 2026NBIM-’1748 — planned Phase 1 · Trial initiationCompany presentation ↗
Cash

Chart & Events

Candle interval

Core Clinical

NBI-’570

M1 × M4

PreINDP1P2P3FilingApproved

CRF1 receptor

PreINDP1P3FilingApproved
Upcoming / outlook

PreINDP2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

AMPA receptor

PreINDP1P2P3FilingApproved
Upcoming / outlook

NBIP-’2118

CRF2 receptor

PreINDP1P2P3FilingApproved
Upcoming / outlook

PreINDP2P3FilingApproved
Upcoming / outlook

NBI-’890

VMAT2

PreINDP1P2P3FilingApproved
Upcoming / outlook

M1 × M4

PreINDP2P3FilingApproved
Upcoming / outlook

Nav1.2 × Nav1.6

PreINDP2P3FilingApproved
Upcoming / outlook

M4 muscarinic receptor

PreINDP1P2P3FilingApproved
Upcoming / outlook

PreINDP2P3FilingApproved
Upcoming / outlook

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

PreINDP2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

PreINDP2P3FilingApproved
Upcoming / outlook

M1 × M4

PreINDP2P3FilingApproved
Upcoming / outlook

NBIP-’2118

CRF2 receptor

PreINDP1P2P3FilingApproved
Upcoming / outlook

Other pipelines

TAK-041

GPR139

PreINDP1P2P3FilingApproved
TAK-041

GPR139

PreINDP1P2P3FilingApproved
NBI-1117567

M1-preferring M1/M4 muscarinic agonist

PreINDP1P2P3FilingApproved
NBI-1117570

M1 muscarinic receptor × M4 muscarinic receptor

PreINDP1P2P3FilingApproved

Nav1.2 × Nav1.6

PreINDP1P2P3FilingApproved

GLP-1 receptor × GIP receptor × Glucagon receptor

PreINDP1P2P3FilingApproved
NBI-1117567

M1 muscarinic receptor × M4 muscarinic receptor

PreINDP1P2P3FilingApproved

PreINDP1P2P3FilingApproved
HTL-0016878

M4 receptor

PreINDP1P2P3FilingApproved

Small molecule

VMAT2

PreINDP1P2P3FilingApproved
NBI-1076986

Small molecule

M4 muscarinic receptor

PreINDP1P2P3FilingApproved

Approved / commercial

PreINDP1P2P3FilingApproved

History / paused

TAK-041

GPR139

PreINDP1P2P3FilingApproved

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

NBIX PR & News

PR & News

NBIX SEC archive